Physician profile
David Simckes
NPI 1881600773
$1,789.94
in general payments reported to CMS, 2019-2025
14 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $72.50 · 2021: $209 · 2022: $244 · 2023: $319 · 2024: $380 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $761.40 | 2019-2025 | Menopur |
| Organon LLC | $426.52 | 2021-2025 | Follistim Aq, Ganirelix Acetate |
| Novo Nordisk INC | $206.86 | 2019-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $99.79 | 2019-2021 | |
| Ascend Therapeutics US, LLC | $70.40 | 2022-2023 | |
| Avion Pharmaceuticals | $41.06 | 2021-2022 | |
| Meditrina | $35.81 | 2021 | |
| Mayne Pharma Commercial LLC | $27.20 | 2023 | |
| Therapeuticsmd, INC. | $26.26 | 2020 | |
| Coopersurgical, INC. | $24.53 | 2025 | Origio Sequential Fert |
| Covidien Lp | $21.26 | 2019 | |
| Hologic Sales and Service, LLC | $19.92 | 2023 | Myosure Tissue Removal Device, Coolseal Generator, Fluent Fluid Management System |
| Minerva Surgical, INC | $15.08 | 2025 | |
| Pfizer INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Simckes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.